[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BowTiedBiotech 🧪🔬🧬 [@BowTiedBiotech](/creator/twitter/BowTiedBiotech) on x 19.6K followers Created: 2025-05-15 11:22:10 UTC Top XX Pharma M&A Projections Brought To You By Grok Top XX Takeover Predictions: 1️⃣ Viking Therapeutics ( $VKTX, $5B, GLP-1) VK2735 could appeal to $LLY 2️⃣ Structure Therapeutics ( $GPCR, $2B, GLP-1) Oral GSBR-1290 fits $PFE needs 3️⃣ Hanmi Science ( KOSDAQ:128940, $3B, GLP-1) Strong IP, could attract $SNY 4️⃣ Zealand Pharma ( CPH:ZEAL, $4B, GLP-1) Innovative pipeline, suits $GSK 5️⃣ BioAtla ( $BCAB, $1.5B, immuno-oncology) Target diversity, fits $MRK model 6️⃣ ImCyse (Private, $1B, immunology) Precision immunology, right for $RHHBY 7️⃣ Rubius Therapeutics (Private, $2B, radiopharma) Early but intriguing, could suit $AMGN 8️⃣ Vectus Biosystems ( ASX:VBS, $0.5B, GLP-1) Small but relevant for $NVO 9️⃣ Orgenesis ( $ORGS, $1B, cell therapy) Scalable model, fits $AZN’s strategy 🔟 Ambrx Biopharma ( $AMAM, $2B, radiopharma) Oncology focus fits $JNJ  XXXXXX engagements  **Related Topics** [drugs](/topic/drugs) [surge](/topic/surge) [$gsk](/topic/$gsk) [$4b](/topic/$4b) [$zealco](/topic/$zealco) [$sny](/topic/$sny) [$3b](/topic/$3b) [$008930ks](/topic/$008930ks) [Post Link](https://x.com/BowTiedBiotech/status/1922975790993440911)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BowTiedBiotech 🧪🔬🧬 @BowTiedBiotech on x 19.6K followers
Created: 2025-05-15 11:22:10 UTC
Top XX Pharma M&A Projections Brought To You By Grok
Top XX Takeover Predictions:
1️⃣ Viking Therapeutics ( $VKTX, $5B, GLP-1) VK2735 could appeal to $LLY
2️⃣ Structure Therapeutics ( $GPCR, $2B, GLP-1) Oral GSBR-1290 fits $PFE needs
3️⃣ Hanmi Science ( KOSDAQ:128940, $3B, GLP-1) Strong IP, could attract $SNY
4️⃣ Zealand Pharma ( CPH:ZEAL, $4B, GLP-1) Innovative pipeline, suits $GSK
5️⃣ BioAtla ( $BCAB, $1.5B, immuno-oncology) Target diversity, fits $MRK model
6️⃣ ImCyse (Private, $1B, immunology) Precision immunology, right for $RHHBY
7️⃣ Rubius Therapeutics (Private, $2B, radiopharma) Early but intriguing, could suit $AMGN
8️⃣ Vectus Biosystems ( ASX:VBS, $0.5B, GLP-1) Small but relevant for $NVO
9️⃣ Orgenesis ( $ORGS, $1B, cell therapy) Scalable model, fits $AZN’s strategy
🔟 Ambrx Biopharma ( $AMAM, $2B, radiopharma) Oncology focus fits $JNJ
XXXXXX engagements
Related Topics drugs surge $gsk $4b $zealco $sny $3b $008930ks
/post/tweet::1922975790993440911